The chitosan-based hemostasis management products market is projected to grow from USD 1.6 billion in 2026 to USD 4.3 billion by 2036, at a CAGR of 10.4%. Hemostatic dressings will dominate with a 36.0% market share, while surgical hemostasis will lead the clinical applications segment with a 42.0% share.